Corcept Therapeutics, Inc. (CORT)
43.75
-0.15
(-0.34%)
USD |
NASDAQ |
Apr 16, 15:00
Corcept Therapeutics Research and Development Expense (Quarterly) : 64.86M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.499B |
| Terns Pharmaceuticals, Inc. | 18.90M |
| Integer Holdings Corp. | 10.11M |
| Ultragenyx Pharmaceutical, Inc. | 194.22M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |